Open Access
Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study
Shuya Li, Yuesong Pan, Ziran Wang, Zhigang Liang, Huisheng Chen, Dong Wang, Yi Sui, Xingquan Zhao, Yilong Wang, WanLiang Du, Huaguang Zheng, Yongjun Wang
DOI: 10.1136/svn-2021-000978 Published 25 February 2022
Shuya Li
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Beijing, China
Yuesong Pan
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Beijing, China
Ziran Wang
3
Department of Neurology, Linyi People's Hospital, Linyi, China
Zhigang Liang
4
Department of Neurology, Affiliated Yantai Yuhuangding Hospital of Qingdao University Medical College, YanTai, China
Huisheng Chen
5
Department of Neurology, General Hospital of Northern Theatre Command, Shenyang, Liaoning, China
Dong Wang
6
Department of Neurology, Baogang Hospital of Inner Monglia, Inner Monglia, China
Yi Sui
7
Department of Neurology, The First People’s Hospital of Shenyang, Shenyang, China
Xingquan Zhao
8
Neurology, Beijing Tiantan Hospital, Beijing, China
Yilong Wang
8
Neurology, Beijing Tiantan Hospital, Beijing, China
WanLiang Du
2
Department of Neurology, Beijing Tiantan Hospital, Beijing, China
Huaguang Zheng
8
Neurology, Beijing Tiantan Hospital, Beijing, China
Yongjun Wang
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Beijing, China

Submit a Response to This Article
No eLetters have been published for this article.
Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study
Shuya Li, Yuesong Pan, Ziran Wang, Zhigang Liang, Huisheng Chen, Dong Wang, Yi Sui, Xingquan Zhao, Yilong Wang, WanLiang Du, Huaguang Zheng, Yongjun Wang
Stroke and Vascular Neurology Feb 2022, 7 (1) 47-53; DOI: 10.1136/svn-2021-000978

Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study
Shuya Li, Yuesong Pan, Ziran Wang, Zhigang Liang, Huisheng Chen, Dong Wang, Yi Sui, Xingquan Zhao, Yilong Wang, WanLiang Du, Huaguang Zheng, Yongjun Wang
Stroke and Vascular Neurology Feb 2022, 7 (1) 47-53; DOI: 10.1136/svn-2021-000978
Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study
Shuya Li, Yuesong Pan, Ziran Wang, Zhigang Liang, Huisheng Chen, Dong Wang, Yi Sui, Xingquan Zhao, Yilong Wang, WanLiang Du, Huaguang Zheng, Yongjun Wang
Stroke and Vascular Neurology Feb 2022, 7 (1) 47-53; DOI: 10.1136/svn-2021-000978